| Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
1110001D
15Rik |  |
NM_026763 |
RIKEN cDNA 1110001D15 gene (1110001D15Rik), mRNA [NM_026763] |
KLA | 1.01 |
1.00 |
1.05 |
1.06 |
1.06 |
1.07 |
1.04 |
| ATP | 1.03 |
1.02 |
1.06 |
1.03 |
1.09 |
1.11 |
.95 |
| KLA/ATP | 1.04 |
1.02 |
1.07 |
1.05 |
1.01 |
1.06 |
1.04 |
|
1810009J
06Rik |  |
NM_023707 |
RIKEN cDNA 1810009J06 gene (1810009J06Rik), mRNA [NM_023707] |
KLA | .94 |
1.09 |
1.01 |
.98 |
1.05 |
.99 |
1.19 |
| ATP | .96 |
.90 |
.96 |
1.04 |
.99 |
1.07 |
1.05 |
| KLA/ATP | 1.02 |
.98 |
1.01 |
1.09 |
1.08 |
1.06 |
1.01 |
|
2210010C
04Rik |  |
NM_023333 |
RIKEN cDNA 2210010C04 gene (2210010C04Rik), mRNA [NM_023333] |
KLA | 1.36 |
1.41 |
1.44 |
1.22 |
1.24 |
1.13 |
1.10 |
| ATP | 1.02 |
.98 |
1.05 |
.96 |
1.01 |
1.02 |
1.06 |
| KLA/ATP | 1.35 |
1.18 |
1.33 |
1.15 |
1.02 |
1.06 |
1.09 |
|
| Ace2 |  |
NM_027286 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (Ace2), mRNA [NM_027286] |
KLA | 1.08 |
.98 |
.99 |
1.06 |
.98 |
.99 |
1.07 |
| ATP | 1.03 |
.99 |
1.04 |
.97 |
1.02 |
1.01 |
1.00 |
| KLA/ATP | .98 |
1.03 |
.96 |
1.00 |
1.08 |
1.06 |
1.00 |
|
AK078587
|  |
AK078587 |
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] |
KLA | 1.37 |
1.28 |
1.13 |
1.06 |
1.15 |
1.31 |
1.22 |
| ATP | 1.04 |
1.08 |
1.21 |
1.22 |
1.27 |
1.12 |
1.14 |
| KLA/ATP | 1.48 |
1.66 |
1.97 |
1.26 |
1.17 |
1.03 |
1.28 |
|
| Atp1a1 |  |
NM_144900 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] |
KLA | .78 |
.94 |
.68 |
.81 |
.62 |
.55 |
.75 |
| ATP | 1.02 |
1.05 |
.86 |
.85 |
1.77 |
2.54 |
1.11 |
| KLA/ATP | .83 |
.99 |
.80 |
.75 |
.91 |
1.15 |
.68 |
|
| Atp1a2 |  |
NM_178405 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] |
KLA | 1.03 |
.98 |
1.03 |
1.05 |
1.03 |
.98 |
1.02 |
| ATP | 1.03 |
.98 |
1.06 |
1.05 |
1.05 |
.93 |
1.07 |
| KLA/ATP | 1.04 |
1.05 |
1.02 |
1.02 |
.98 |
.92 |
1.02 |
|
| Atp1a3 |  |
AK053751 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] |
KLA | .88 |
.87 |
.74 |
.80 |
.84 |
.88 |
.93 |
| ATP | .96 |
.83 |
.80 |
.88 |
.94 |
.89 |
1.15 |
| KLA/ATP | .89 |
.86 |
.79 |
.90 |
.93 |
.84 |
.92 |
|
| Atp1a3 | |
NM_144921 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] |
KLA | .99 |
.87 |
.96 |
.86 |
.81 |
.61 |
.52 |
| ATP | 1.22 |
1.21 |
1.16 |
1.38 |
1.27 |
.92 |
1.30 |
| KLA/ATP | .96 |
1.10 |
1.17 |
1.42 |
1.11 |
.91 |
.93 |
|
| Atp1b1 |  |
NM_009721 |
ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] |
KLA | .97 |
1.02 |
1.08 |
.98 |
.95 |
1.01 |
1.09 |
| ATP | 1.07 |
1.05 |
1.09 |
1.09 |
1.02 |
1.17 |
1.11 |
| KLA/ATP | .99 |
.99 |
.93 |
1.02 |
1.00 |
1.07 |
1.04 |
|
| Atp1b2 |  |
NM_013415 |
ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] |
KLA | 1.18 |
1.09 |
1.11 |
1.12 |
1.16 |
1.12 |
1.15 |
| ATP | .95 |
.98 |
.99 |
1.26 |
1.06 |
1.10 |
1.07 |
| KLA/ATP | 1.15 |
1.16 |
1.09 |
1.19 |
1.27 |
1.13 |
1.02 |
|
| Atp1b3 |  |
NM_007502 |
ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] |
KLA | 1.86 |
2.10 |
2.25 |
2.21 |
2.68 |
3.26 |
3.45 |
| ATP | 1.08 |
1.09 |
.93 |
1.13 |
1.55 |
2.14 |
2.38 |
| KLA/ATP | 1.95 |
2.10 |
1.84 |
2.34 |
2.20 |
2.96 |
4.69 |
|
| Atp1b4 |  |
NM_133690 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] |
KLA | .99 |
1.02 |
1.03 |
1.01 |
.95 |
.90 |
1.00 |
| ATP | 1.00 |
1.05 |
1.04 |
.98 |
1.07 |
.98 |
.97 |
| KLA/ATP | 1.00 |
1.05 |
1.03 |
1.04 |
.96 |
.97 |
1.01 |
|
| Col11a1 |  |
AK021265 |
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530001D20 product:unclassifiable, full insert sequence. [AK021265] |
KLA | 1.02 |
1.01 |
1.03 |
1.06 |
1.02 |
1.03 |
1.05 |
| ATP | .97 |
.92 |
1.02 |
.96 |
.93 |
1.11 |
1.00 |
| KLA/ATP | 1.01 |
.96 |
.97 |
1.00 |
1.04 |
.89 |
1.08 |
|
| Col11a1 | |
NM_007729 |
collagen, type XI, alpha 1 (Col11a1), mRNA [NM_007729] |
KLA | 1.06 |
1.06 |
1.10 |
1.05 |
1.07 |
1.01 |
1.09 |
| ATP | .97 |
.93 |
.95 |
1.03 |
.96 |
1.01 |
1.05 |
| KLA/ATP | 1.03 |
.98 |
1.02 |
1.02 |
.97 |
.99 |
1.05 |
|
| Col11a2 |  |
NM_009926 |
collagen, type XI, alpha 2 (Col11a2), mRNA [NM_009926] |
KLA | 5.62 |
5.61 |
5.24 |
4.99 |
3.69 |
1.95 |
1.14 |
| ATP | .95 |
.95 |
1.17 |
1.59 |
1.73 |
1.28 |
1.12 |
| KLA/ATP | 5.25 |
5.62 |
6.37 |
5.73 |
4.79 |
2.22 |
1.39 |
|
| Col12a1 |  |
NM_007730 |
collagen, type XII, alpha 1 (Col12a1), mRNA [NM_007730] |
KLA | 1.00 |
1.00 |
1.04 |
.99 |
1.05 |
.94 |
.96 |
| ATP | 1.00 |
1.03 |
1.01 |
1.04 |
.98 |
1.02 |
.99 |
| KLA/ATP | 1.01 |
.92 |
1.02 |
1.01 |
.99 |
.97 |
1.06 |
|
| Col13a1 |  |
NM_007731 |
collagen, type XIII, alpha 1 (Col13a1), mRNA [NM_007731] |
KLA | 1.03 |
1.00 |
1.01 |
1.00 |
.99 |
1.05 |
1.03 |
| ATP | .99 |
1.00 |
1.01 |
1.01 |
1.01 |
1.00 |
1.05 |
| KLA/ATP | 1.03 |
1.02 |
.97 |
1.02 |
1.03 |
1.05 |
.93 |
|
| Col14a1 |  |
NM_181277 |
collagen, type XIV, alpha 1 (Col14a1), mRNA [NM_181277] |
KLA | .95 |
.95 |
.97 |
.94 |
.93 |
.95 |
.92 |
| ATP | .98 |
1.16 |
1.04 |
.99 |
.95 |
.91 |
.98 |
| KLA/ATP | .93 |
.94 |
.94 |
.99 |
.92 |
.94 |
.94 |
|
| Col15a1 |  |
NM_009928 |
collagen, type XV, alpha 1 (Col15a1), mRNA [NM_009928] |
KLA | 1.20 |
1.24 |
1.19 |
1.12 |
1.01 |
.99 |
.97 |
| ATP | 1.02 |
1.01 |
1.06 |
1.12 |
1.15 |
1.01 |
1.03 |
| KLA/ATP | 1.28 |
1.27 |
1.13 |
1.06 |
1.01 |
1.00 |
1.01 |
|
| Col17a1 |  |
NM_007732 |
collagen, type XVII, alpha 1 (Col17a1), mRNA [NM_007732] |
KLA | .97 |
1.03 |
.98 |
.97 |
1.02 |
.99 |
1.05 |
| ATP | 1.06 |
.89 |
.99 |
1.05 |
1.02 |
.95 |
1.03 |
| KLA/ATP | .97 |
1.00 |
.99 |
.97 |
1.05 |
1.06 |
1.00 |
|
| Col18a1 |  |
NM_009929 |
collagen, type XVIII, alpha 1 (Col18a1), transcript variant 2, mRNA [NM_009929] |
KLA | 1.80 |
1.78 |
1.77 |
1.47 |
1.33 |
.93 |
.61 |
| ATP | 1.03 |
1.10 |
1.12 |
1.12 |
.90 |
.85 |
3.77 |
| KLA/ATP | 1.86 |
2.06 |
1.88 |
1.81 |
1.28 |
.81 |
1.14 |
|
| Col1a1 |  |
NM_007742 |
collagen, type I, alpha 1 (Col1a1), mRNA [NM_007742] |
KLA | 1.13 |
1.10 |
1.22 |
1.18 |
1.04 |
1.15 |
1.09 |
| ATP | 1.03 |
1.00 |
1.34 |
1.48 |
1.11 |
1.13 |
1.11 |
| KLA/ATP | 1.13 |
1.29 |
1.47 |
1.77 |
1.38 |
1.33 |
1.13 |
|
| Col1a2 |  |
AK031577 |
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030456A07 product:procollagen, type I, alpha 2, full insert sequence. [AK031577] |
KLA | .98 |
1.03 |
1.02 |
1.01 |
1.03 |
1.01 |
.90 |
| ATP | .97 |
.96 |
.96 |
1.00 |
.92 |
1.00 |
1.00 |
| KLA/ATP | .97 |
1.00 |
1.02 |
1.06 |
.96 |
.98 |
1.00 |
|
| Col1a2 | |
NM_007743 |
collagen, type I, alpha 2 (Col1a2), mRNA [NM_007743] |
KLA | 1.25 |
1.20 |
1.58 |
1.41 |
1.32 |
1.51 |
1.08 |
| ATP | .92 |
.97 |
1.50 |
1.66 |
1.38 |
1.23 |
1.14 |
| KLA/ATP | 1.35 |
1.46 |
2.19 |
2.47 |
1.99 |
1.64 |
1.36 |
|
| Col22a1 |  |
XM_981889 |
gb|PREDICTED: Mus musculus collagen, type XXII, alpha 1, transcript variant 2 (Col22a1), mRNA [XM_981889] |
KLA | 1.26 |
1.46 |
1.62 |
1.66 |
1.76 |
2.29 |
1.98 |
| ATP | 1.01 |
1.03 |
1.13 |
1.20 |
1.12 |
1.14 |
1.96 |
| KLA/ATP | 1.40 |
1.52 |
1.53 |
1.48 |
1.67 |
1.85 |
2.54 |
|
| Col24a1 |  |
NM_027770 |
collagen, type XXIV, alpha 1 (Col24a1), mRNA [NM_027770] |
KLA | .96 |
1.03 |
.95 |
.99 |
1.01 |
1.02 |
.98 |
| ATP | .98 |
1.03 |
1.04 |
1.04 |
.95 |
.99 |
1.00 |
| KLA/ATP | 1.04 |
.98 |
1.01 |
.99 |
1.01 |
.93 |
.96 |
|
| Col27a1 |  |
AK076297 |
0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632427K15 product:procollagen, type XXVII, alpha 1, full insert sequence. [AK076297] |
KLA | 1.19 |
1.39 |
1.10 |
1.06 |
1.01 |
1.04 |
.96 |
| ATP | 1.00 |
.99 |
1.02 |
.99 |
1.01 |
1.06 |
1.08 |
| KLA/ATP | 1.23 |
1.26 |
1.12 |
1.10 |
1.12 |
.95 |
1.03 |
|
| Col27a1 | |
NM_025685 |
collagen, type XXVII, alpha 1 (Col27a1), mRNA [NM_025685] |
KLA | 3.10 |
3.05 |
2.89 |
1.86 |
1.37 |
1.14 |
1.16 |
| ATP | 1.02 |
1.00 |
1.10 |
1.22 |
1.24 |
1.15 |
1.12 |
| KLA/ATP | 3.43 |
3.57 |
2.62 |
1.99 |
1.42 |
1.23 |
1.24 |
|
| Col2a1 |  |
AK053784 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130308G17 product:unclassifiable, full insert sequence. [AK053784] |
KLA | .95 |
.97 |
1.05 |
.93 |
.94 |
.94 |
.98 |
| ATP | .99 |
.91 |
.97 |
.87 |
.99 |
1.03 |
.93 |
| KLA/ATP | .95 |
1.05 |
.95 |
1.01 |
.97 |
.97 |
1.00 |
|
| Col2a1 | |
NM_031163 |
collagen, type II, alpha 1 (Col2a1), transcript variant 1, mRNA [NM_031163] |
KLA | 1.20 |
1.28 |
1.29 |
1.21 |
1.33 |
1.24 |
1.21 |
| ATP | .98 |
1.02 |
1.02 |
1.09 |
1.02 |
1.01 |
1.09 |
| KLA/ATP | 1.33 |
1.28 |
1.09 |
1.32 |
1.15 |
1.12 |
1.17 |
|
| Col3a1 |  |
AK031544 |
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030449K06 product:PROCOLLAGEN, TYPE III, ALPHA 1 (FRAGMENT) homolog [Mus musculus], full insert sequence. [AK031544] |
KLA | 1.04 |
.95 |
1.01 |
1.04 |
1.04 |
1.03 |
.97 |
| ATP | 1.00 |
.98 |
1.02 |
1.00 |
1.03 |
1.00 |
.98 |
| KLA/ATP | 1.11 |
1.03 |
1.05 |
.90 |
.95 |
1.01 |
.97 |
|
| Col3a1 | |
NM_009930 |
collagen, type III, alpha 1 (Col3a1), mRNA [NM_009930] |
KLA | 1.06 |
1.08 |
1.02 |
.99 |
1.02 |
1.03 |
.99 |
| ATP | .97 |
1.01 |
1.07 |
1.01 |
.92 |
.94 |
.99 |
| KLA/ATP | .97 |
.99 |
1.09 |
1.11 |
.98 |
1.00 |
1.02 |
|
| Col4a1 |  |
NM_009931 |
collagen, type IV, alpha 1 (Col4a1), mRNA [NM_009931] |
KLA | 1.13 |
1.19 |
1.12 |
1.09 |
1.04 |
.89 |
.90 |
| ATP | 1.01 |
1.17 |
1.02 |
1.04 |
.91 |
.89 |
.97 |
| KLA/ATP | 1.14 |
1.24 |
1.03 |
1.15 |
.95 |
.86 |
1.01 |
|
| Col4a2 |  |
NM_009932 |
collagen, type IV, alpha 2 (Col4a2), mRNA [NM_009932] |
KLA | 1.30 |
1.45 |
1.54 |
1.40 |
1.71 |
1.71 |
2.12 |
| ATP | 1.09 |
1.07 |
.98 |
1.03 |
.92 |
1.21 |
1.42 |
| KLA/ATP | 1.45 |
1.53 |
1.24 |
1.29 |
1.16 |
1.57 |
3.31 |
|
| Col4a3 |  |
NM_007734 |
collagen, type IV, alpha 3 (Col4a3), mRNA [NM_007734] |
KLA | 1.09 |
1.11 |
1.12 |
1.10 |
1.05 |
1.06 |
1.04 |
| ATP | 1.02 |
1.03 |
1.01 |
.99 |
1.01 |
1.07 |
1.07 |
| KLA/ATP | 1.04 |
1.13 |
1.01 |
1.09 |
1.02 |
.98 |
1.01 |
|
| Col4a4 |  |
NM_007735 |
collagen, type IV, alpha 4 (Col4a4), mRNA [NM_007735] |
KLA | 1.35 |
1.29 |
1.33 |
1.39 |
1.30 |
1.18 |
.98 |
| ATP | 1.14 |
1.08 |
1.30 |
1.54 |
1.54 |
1.34 |
.93 |
| KLA/ATP | 1.37 |
1.41 |
1.70 |
1.88 |
1.67 |
1.29 |
1.19 |
|
| Col4a5 |  |
NM_007736 |
collagen, type IV, alpha 5 (Col4a5), mRNA [NM_007736] |
KLA | 1.00 |
.95 |
.95 |
.82 |
.72 |
.58 |
.70 |
| ATP | 1.05 |
1.18 |
.98 |
.88 |
.56 |
.53 |
.57 |
| KLA/ATP | 1.04 |
1.05 |
.83 |
.82 |
.58 |
.49 |
.61 |
|
| Col4a6 |  |
NM_053185 |
collagen, type IV, alpha 6 (Col4a6), mRNA [NM_053185] |
KLA | 1.06 |
1.04 |
1.00 |
1.07 |
.94 |
.93 |
.94 |
| ATP | .97 |
.96 |
1.18 |
1.10 |
1.07 |
1.04 |
.86 |
| KLA/ATP | 1.00 |
1.05 |
1.22 |
1.06 |
1.12 |
1.02 |
.93 |
|
| Col5a1 |  |
NM_015734 |
collagen, type V, alpha 1 (Col5a1), mRNA [NM_015734] |
KLA | 1.00 |
.99 |
1.07 |
1.01 |
1.03 |
1.01 |
1.10 |
| ATP | 1.02 |
.98 |
1.02 |
1.07 |
.96 |
1.01 |
1.09 |
| KLA/ATP | 1.03 |
1.01 |
1.08 |
1.08 |
1.01 |
1.09 |
1.08 |
|
| Col5a2 |  |
NM_007737 |
collagen, type V, alpha 2 (Col5a2), mRNA [NM_007737] |
KLA | .96 |
1.01 |
1.12 |
1.03 |
.99 |
.98 |
.90 |
| ATP | .99 |
1.06 |
1.05 |
1.10 |
.90 |
.98 |
1.06 |
| KLA/ATP | .95 |
1.01 |
1.05 |
1.11 |
1.07 |
1.04 |
1.14 |
|
| Col5a3 |  |
NM_016919 |
collagen, type V, alpha 3 (Col5a3), mRNA [NM_016919] |
KLA | 1.33 |
1.48 |
1.48 |
1.47 |
1.45 |
1.31 |
1.08 |
| ATP | 1.06 |
1.02 |
1.08 |
1.06 |
1.07 |
1.35 |
1.48 |
| KLA/ATP | 1.42 |
1.50 |
1.42 |
1.45 |
1.27 |
1.32 |
1.37 |
|
| Col6a1 |  |
NM_009933 |
collagen, type VI, alpha 1 (Col6a1), mRNA [NM_009933] |
KLA | 1.08 |
1.12 |
1.29 |
1.16 |
1.17 |
.96 |
1.03 |
| ATP | 1.05 |
1.03 |
1.01 |
1.07 |
.98 |
.96 |
.88 |
| KLA/ATP | 1.16 |
1.18 |
.92 |
1.17 |
1.01 |
.98 |
.92 |
|
| Col6a2 |  |
AK044870 |
9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130009B12 product:procollagen, type VI, alpha 2, full insert sequence. [AK044870] |
KLA | 1.06 |
1.00 |
.99 |
.96 |
.96 |
1.00 |
1.01 |
| ATP | .95 |
.95 |
.92 |
1.10 |
1.09 |
1.03 |
1.01 |
| KLA/ATP | 1.01 |
.97 |
.98 |
1.04 |
.98 |
1.04 |
.96 |
|
| Col6a2 | |
NM_146007 |
collagen, type VI, alpha 2 (Col6a2), mRNA [NM_146007] |
KLA | .94 |
1.06 |
1.00 |
1.07 |
1.05 |
1.04 |
1.00 |
| ATP | 1.01 |
.99 |
1.02 |
1.01 |
1.00 |
1.01 |
.98 |
| KLA/ATP | 1.01 |
.99 |
1.04 |
1.01 |
1.08 |
1.01 |
.95 |
|
| Col6a3 |  |
AF034136 |
collagen alpha3(VI) (Col6a3) mRNA, partial cds [AF034136] |
KLA | .97 |
1.00 |
1.03 |
1.00 |
1.03 |
1.04 |
1.06 |
| ATP | 1.00 |
.93 |
1.00 |
1.01 |
1.07 |
.97 |
1.01 |
| KLA/ATP | 1.08 |
1.04 |
1.05 |
1.04 |
.99 |
1.10 |
1.02 |
|
| Col7a1 |  |
NM_007738 |
collagen, type VII, alpha 1 (Col7a1), mRNA [NM_007738] |
KLA | 1.04 |
1.05 |
.99 |
1.09 |
1.24 |
1.76 |
1.40 |
| ATP | .88 |
.85 |
.98 |
1.08 |
2.79 |
3.28 |
1.35 |
| KLA/ATP | 1.04 |
1.02 |
1.19 |
1.05 |
2.62 |
2.69 |
1.75 |
|
| Col9a1 |  |
NM_007740 |
collagen, type IX, alpha 1 (Col9a1), mRNA [NM_007740] |
KLA | 1.09 |
.98 |
1.01 |
1.03 |
1.03 |
1.01 |
1.03 |
| ATP | .96 |
1.03 |
1.04 |
.98 |
.99 |
.97 |
.95 |
| KLA/ATP | .99 |
1.00 |
1.08 |
1.00 |
1.00 |
.95 |
.96 |
|
| Col9a2 |  |
NM_007741 |
collagen, type IX, alpha 2 (Col9a2), mRNA [NM_007741] |
KLA | 1.15 |
1.13 |
1.21 |
1.17 |
1.16 |
1.12 |
1.20 |
| ATP | 1.02 |
1.03 |
1.02 |
1.21 |
1.07 |
.96 |
.98 |
| KLA/ATP | 1.16 |
1.23 |
1.04 |
1.23 |
1.03 |
1.05 |
1.08 |
|
| Col9a3 |  |
NM_009936 |
collagen, type IX, alpha 3 (Col9a3), mRNA [NM_009936] |
KLA | 1.36 |
1.37 |
1.52 |
1.27 |
1.34 |
1.43 |
2.13 |
| ATP | 1.04 |
.99 |
.96 |
1.16 |
1.03 |
1.16 |
.96 |
| KLA/ATP | 1.44 |
1.29 |
1.11 |
1.29 |
1.60 |
1.45 |
1.08 |
|
| Cpa1 |  |
NM_025350 |
carboxypeptidase A1 (Cpa1), mRNA [NM_025350] |
KLA | 1.09 |
1.08 |
.95 |
1.04 |
.99 |
.98 |
1.02 |
| ATP | .95 |
1.04 |
1.02 |
.93 |
.98 |
.99 |
1.06 |
| KLA/ATP | .93 |
1.00 |
1.01 |
.91 |
.99 |
.99 |
1.07 |
|
| Cpa2 |  |
NM_001024698 |
carboxypeptidase A2, pancreatic (Cpa2), mRNA [NM_001024698] |
KLA | .90 |
.92 |
.91 |
.88 |
.84 |
.91 |
1.13 |
| ATP | 1.00 |
.96 |
.92 |
.94 |
.87 |
.92 |
.98 |
| KLA/ATP | .94 |
.90 |
.84 |
.83 |
.92 |
.82 |
1.01 |
|
| Cpa3 |  |
NM_007753 |
carboxypeptidase A3, mast cell (Cpa3), mRNA [NM_007753] |
KLA | 1.03 |
1.11 |
1.20 |
1.04 |
1.10 |
1.05 |
1.00 |
| ATP | .99 |
.98 |
.99 |
.93 |
.94 |
1.02 |
.93 |
| KLA/ATP | 1.02 |
1.11 |
1.08 |
1.03 |
.96 |
1.02 |
.93 |
|
| Cpb1 |  |
NM_029706 |
carboxypeptidase B1 (tissue) (Cpb1), mRNA [NM_029706] |
KLA | 1.01 |
1.07 |
1.10 |
1.08 |
1.05 |
1.17 |
1.00 |
| ATP | .94 |
.95 |
1.02 |
.98 |
.95 |
1.05 |
1.00 |
| KLA/ATP | 1.02 |
1.02 |
1.09 |
1.04 |
1.12 |
1.07 |
1.26 |
|
| Cpb2 |  |
AK015095 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930405E17 product:unclassifiable, full insert sequence. [AK015095] |
KLA | 1.00 |
.93 |
.99 |
1.01 |
.99 |
1.00 |
.95 |
| ATP | .96 |
1.02 |
.98 |
.95 |
1.01 |
.98 |
1.01 |
| KLA/ATP | .96 |
.99 |
.92 |
.97 |
.98 |
1.04 |
1.00 |
|
| Cpb2 | |
NM_019775 |
carboxypeptidase B2 (plasma) (Cpb2), mRNA [NM_019775] |
KLA | 1.13 |
1.19 |
.95 |
1.16 |
1.03 |
1.01 |
.84 |
| ATP | .98 |
1.23 |
.91 |
1.00 |
.88 |
1.06 |
1.07 |
| KLA/ATP | 1.08 |
1.25 |
1.10 |
1.12 |
1.15 |
1.07 |
1.12 |
|
| Ctrb1 |  |
NM_025583 |
chymotrypsinogen B1 (Ctrb1), mRNA [NM_025583] |
KLA | 1.52 |
1.57 |
1.59 |
1.66 |
1.67 |
1.79 |
1.23 |
| ATP | .91 |
.95 |
1.22 |
1.28 |
1.30 |
1.54 |
1.18 |
| KLA/ATP | 1.51 |
1.60 |
1.92 |
1.72 |
1.65 |
1.54 |
1.47 |
|
| Ctrl |  |
NM_023182 |
chymotrypsin-like (Ctrl), mRNA [NM_023182] |
KLA | 1.82 |
1.98 |
2.08 |
1.93 |
2.02 |
2.01 |
1.53 |
| ATP | 1.09 |
1.17 |
1.29 |
1.39 |
1.69 |
1.97 |
1.26 |
| KLA/ATP | 2.43 |
2.69 |
4.20 |
5.20 |
4.65 |
3.05 |
2.28 |
|
| Dpp4 |  |
NM_010074 |
dipeptidylpeptidase 4 (Dpp4), mRNA [NM_010074] |
KLA | 1.02 |
1.05 |
1.09 |
1.06 |
1.07 |
1.11 |
1.07 |
| ATP | 1.07 |
1.00 |
1.03 |
1.05 |
1.00 |
1.02 |
1.03 |
| KLA/ATP | 1.09 |
1.09 |
1.07 |
1.08 |
1.10 |
1.06 |
1.04 |
|
E330026B
02Rik |  |
NM_172927 |
RIKEN cDNA E330026B02 gene (E330026B02Rik), transcript variant 2, mRNA [NM_172927] |
KLA | .94 |
.98 |
1.02 |
1.02 |
.97 |
1.05 |
.99 |
| ATP | .97 |
.94 |
.98 |
1.02 |
1.02 |
.99 |
1.02 |
| KLA/ATP | 1.01 |
.99 |
1.03 |
1.04 |
.96 |
.97 |
.94 |
|
| Ela3 |  |
NM_026419 |
elastase 3, pancreatic (Ela3), mRNA [NM_026419] |
KLA | 1.02 |
1.02 |
1.05 |
1.08 |
1.11 |
1.10 |
1.13 |
| ATP | .95 |
.99 |
1.04 |
.96 |
.98 |
1.03 |
.98 |
| KLA/ATP | 1.03 |
1.05 |
1.13 |
1.03 |
1.03 |
.93 |
.98 |
|
| Eln |  |
NM_007925 |
elastin (Eln), mRNA [NM_007925] |
KLA | 1.00 |
1.04 |
1.06 |
1.08 |
1.04 |
1.11 |
.95 |
| ATP | 1.00 |
.99 |
1.06 |
1.02 |
.98 |
1.00 |
1.09 |
| KLA/ATP | .96 |
1.03 |
.96 |
1.04 |
.98 |
.97 |
1.03 |
|
| Fxyd2 |  |
NM_052823 |
FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] |
KLA | 1.07 |
.97 |
1.09 |
.98 |
1.02 |
.96 |
.83 |
| ATP | 1.07 |
1.22 |
1.00 |
1.14 |
1.00 |
1.22 |
4.11 |
| KLA/ATP | 1.06 |
1.11 |
.96 |
1.13 |
.98 |
1.01 |
1.02 |
|
| Kcne3 |  |
NM_020574 |
potassium voltage-gated channel, Isk-related subfamily, gene 3 (Kcne3), mRNA [NM_020574] |
KLA | .51 |
.55 |
.57 |
.60 |
.55 |
.45 |
.31 |
| ATP | .96 |
.92 |
1.06 |
.98 |
.72 |
.48 |
.38 |
| KLA/ATP | .53 |
.52 |
.70 |
.62 |
.63 |
.50 |
.34 |
|
| Kcnk5 |  |
NM_021542 |
potassium channel, subfamily K, member 5 (Kcnk5), mRNA [NM_021542] |
KLA | .97 |
.98 |
.99 |
.98 |
.96 |
.98 |
.94 |
| ATP | 1.05 |
1.01 |
.99 |
1.07 |
1.02 |
.95 |
.84 |
| KLA/ATP | .99 |
1.00 |
.95 |
.99 |
1.00 |
.97 |
.89 |
|
| Kcnn4 |  |
NM_008433 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 (Kcnn4), mRNA [NM_008433] |
KLA | .89 |
.85 |
.74 |
.69 |
.78 |
1.04 |
.98 |
| ATP | .95 |
1.03 |
.82 |
.84 |
.81 |
.44 |
.70 |
| KLA/ATP | 1.04 |
.94 |
.65 |
.74 |
.56 |
.43 |
.57 |
|
| Kcnq1 |  |
NM_008434 |
potassium voltage-gated channel, subfamily Q, member 1 (Kcnq1), mRNA [NM_008434] |
KLA | .80 |
.77 |
.67 |
.78 |
.65 |
.54 |
.42 |
| ATP | 1.06 |
.94 |
1.00 |
1.12 |
.97 |
.69 |
.60 |
| KLA/ATP | .75 |
.85 |
.83 |
.87 |
.70 |
.62 |
.56 |
|
| Mep1a |  |
NM_008585 |
meprin 1 alpha (Mep1a), mRNA [NM_008585] |
KLA | 1.16 |
1.18 |
1.16 |
1.22 |
1.15 |
1.31 |
1.25 |
| ATP | .98 |
1.02 |
1.12 |
1.26 |
1.13 |
1.35 |
1.46 |
| KLA/ATP | 1.15 |
1.13 |
1.39 |
1.28 |
1.32 |
1.29 |
1.78 |
|
| Mep1b |  |
NM_008586 |
meprin 1 beta (Mep1b), mRNA [NM_008586] |
KLA | 1.00 |
1.02 |
1.03 |
.98 |
.95 |
1.04 |
1.00 |
| ATP | 1.04 |
1.00 |
1.05 |
1.02 |
.99 |
1.00 |
.97 |
| KLA/ATP | 1.08 |
1.00 |
1.00 |
1.00 |
.97 |
1.03 |
.99 |
|
| Mep1b | |
U36186 |
meprin beta subunit isoform (Mep-1beta) mRNA, unique 5 region and partial cds. [U36186] |
KLA | .98 |
1.01 |
1.01 |
1.03 |
.97 |
.96 |
.96 |
| ATP | .98 |
.97 |
.90 |
.96 |
.98 |
.96 |
.93 |
| KLA/ATP | 1.01 |
1.05 |
1.00 |
.94 |
1.01 |
1.01 |
1.00 |
|
Mm.13451
|  |
194473665 |
Unknown |
KLA | 1.01 |
1.05 |
.93 |
1.09 |
1.00 |
1.00 |
1.00 |
| ATP | 1.00 |
.96 |
1.01 |
.98 |
.94 |
1.02 |
1.05 |
| KLA/ATP | .97 |
.97 |
1.01 |
.98 |
.99 |
.93 |
1.03 |
|
Mm.26885
5 |  |
142350483 |
Unknown |
KLA | .85 |
.82 |
1.01 |
.90 |
.88 |
1.00 |
1.06 |
| ATP | 1.00 |
.99 |
.91 |
.91 |
.93 |
.88 |
.93 |
| KLA/ATP | .90 |
.96 |
.92 |
.87 |
.85 |
.86 |
1.01 |
|
Mm.34692
|  |
56550070 |
Unknown |
KLA | 1.05 |
1.01 |
1.01 |
1.02 |
1.02 |
1.00 |
1.02 |
| ATP | .97 |
1.05 |
1.03 |
1.01 |
1.00 |
.98 |
.95 |
| KLA/ATP | .92 |
1.03 |
1.05 |
1.01 |
.98 |
1.00 |
1.03 |
|
Mm.46042
5 |  |
145699103 |
Unknown |
KLA | .97 |
1.06 |
1.00 |
1.00 |
1.04 |
1.00 |
1.06 |
| ATP | .98 |
1.03 |
.96 |
.96 |
1.00 |
1.05 |
.96 |
| KLA/ATP | .99 |
.95 |
1.04 |
.97 |
1.01 |
.98 |
.93 |
|
| Mme |  |
NM_008604 |
membrane metallo endopeptidase (Mme), mRNA [NM_008604] |
KLA | 1.01 |
1.04 |
1.00 |
1.02 |
1.02 |
.98 |
.98 |
| ATP | .95 |
.98 |
.97 |
.99 |
1.04 |
.96 |
1.01 |
| KLA/ATP | 1.04 |
1.06 |
1.05 |
1.01 |
.98 |
.91 |
1.00 |
|
| Pga5 |  |
NM_021453 |
pepsinogen 5, group I (Pga5), mRNA [NM_021453] |
KLA | .98 |
.99 |
.91 |
1.00 |
.97 |
1.02 |
1.01 |
| ATP | 1.01 |
1.06 |
1.05 |
1.00 |
1.05 |
.96 |
.93 |
| KLA/ATP | 1.04 |
.90 |
1.03 |
1.04 |
.98 |
.95 |
.98 |
|
| Prcp |  |
NM_028243 |
prolylcarboxypeptidase (angiotensinase C) (Prcp), mRNA [NM_028243] |
KLA | .98 |
1.02 |
.92 |
.82 |
.73 |
.76 |
1.01 |
| ATP | 1.04 |
1.15 |
1.08 |
1.34 |
1.40 |
1.59 |
1.48 |
| KLA/ATP | .98 |
1.06 |
.93 |
1.26 |
1.14 |
1.58 |
1.43 |
|
| Prss2 |  |
NM_009430 |
protease, serine, 2 (Prss2), mRNA [NM_009430] |
KLA | .94 |
.99 |
.95 |
1.03 |
.89 |
1.08 |
1.06 |
| ATP | 1.04 |
.95 |
1.00 |
1.03 |
.96 |
.97 |
1.00 |
| KLA/ATP | 1.05 |
.96 |
1.01 |
1.05 |
1.00 |
1.11 |
1.11 |
|
RP23-395
H4.4 |  |
NM_007919 |
elastase 2A (Ela2a), mRNA [NM_007919] |
KLA | 1.02 |
1.00 |
1.01 |
.99 |
1.04 |
.99 |
.99 |
| ATP | 1.03 |
1.01 |
.97 |
.90 |
1.06 |
.99 |
1.00 |
| KLA/ATP | 1.00 |
1.06 |
1.01 |
.97 |
.99 |
1.00 |
.99 |
|
| Slc15a1 |  |
NM_053079 |
solute carrier family 15 (oligopeptide transporter), member 1 (Slc15a1), mRNA [NM_053079] |
KLA | 1.00 |
1.07 |
1.03 |
1.04 |
.93 |
1.06 |
1.01 |
| ATP | 1.01 |
1.00 |
1.02 |
1.01 |
1.01 |
1.01 |
1.00 |
| KLA/ATP | 1.02 |
1.02 |
1.06 |
.97 |
1.00 |
.99 |
1.06 |
|
Slc16a10
|  |
NM_001114332 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 (Slc16a10), transcript variant 1, mRNA [NM_001114332] |
KLA | 1.14 |
1.19 |
.87 |
.80 |
1.16 |
2.20 |
4.54 |
| ATP | 1.05 |
1.14 |
1.12 |
2.31 |
2.38 |
1.41 |
1.53 |
| KLA/ATP | 1.35 |
1.18 |
.86 |
1.68 |
1.69 |
1.25 |
3.63 |
|
Slc16a10
| |
NM_028247 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 (Slc16a10), transcript variant 2, mRNA [NM_028247] |
KLA | 1.21 |
1.31 |
.95 |
.95 |
1.41 |
2.26 |
4.33 |
| ATP | 1.07 |
1.15 |
1.07 |
2.57 |
2.36 |
1.19 |
1.42 |
| KLA/ATP | 1.43 |
1.34 |
.94 |
1.93 |
1.67 |
1.14 |
3.01 |
|
| Slc1a1 |  |
NM_009199 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 (Slc1a1), mRNA [NM_009199] |
KLA | 1.07 |
1.09 |
1.07 |
1.11 |
1.05 |
1.03 |
.98 |
| ATP | 1.01 |
1.00 |
.99 |
1.04 |
1.25 |
1.28 |
1.05 |
| KLA/ATP | 1.12 |
1.03 |
1.09 |
1.09 |
1.07 |
1.07 |
1.22 |
|
| Slc1a5 |  |
NM_009201 |
solute carrier family 1 (neutral amino acid transporter), member 5 (Slc1a5), mRNA [NM_009201] |
KLA | .65 |
.70 |
.56 |
.45 |
.36 |
.25 |
.35 |
| ATP | 1.05 |
1.14 |
1.15 |
2.22 |
2.06 |
1.13 |
.52 |
| KLA/ATP | .73 |
.70 |
.59 |
.93 |
.87 |
.58 |
.22 |
|
| Slc36a1 |  |
NM_153139 |
solute carrier family 36 (proton/amino acid symporter), member 1 (Slc36a1), mRNA [NM_153139] |
KLA | .72 |
.69 |
.72 |
.75 |
1.10 |
1.41 |
1.37 |
| ATP | 1.04 |
1.08 |
1.00 |
.92 |
1.06 |
.99 |
1.34 |
| KLA/ATP | .74 |
.71 |
.69 |
.71 |
.98 |
.92 |
1.50 |
|
| Slc38a2 |  |
AK164568 |
13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330050A21 product:solute carrier family 38, member 2, full insert sequence [AK164568] |
KLA | .49 |
.44 |
.31 |
.39 |
.58 |
.67 |
.87 |
| ATP | 1.52 |
1.82 |
5.27 |
8.64 |
3.25 |
1.48 |
1.13 |
| KLA/ATP | .47 |
.68 |
1.28 |
2.77 |
2.02 |
.86 |
.76 |
|
| Slc38a2 | |
NM_175121 |
solute carrier family 38, member 2 (Slc38a2), mRNA [NM_175121] |
KLA | .45 |
.46 |
.38 |
.34 |
.33 |
.52 |
.73 |
| ATP | 1.04 |
1.22 |
1.93 |
5.44 |
5.96 |
3.34 |
1.39 |
| KLA/ATP | .45 |
.48 |
.58 |
1.67 |
2.62 |
1.71 |
.86 |
|
| Slc3a1 |  |
NM_009205 |
solute carrier family 3, member 1 (Slc3a1), mRNA [NM_009205] |
KLA | 1.02 |
1.08 |
1.05 |
1.08 |
1.03 |
1.02 |
1.04 |
| ATP | .96 |
1.04 |
.96 |
1.04 |
1.24 |
1.29 |
1.05 |
| KLA/ATP | .90 |
1.10 |
1.01 |
1.15 |
1.36 |
1.50 |
1.14 |
|
| Slc3a2 |  |
NM_008577 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (Slc3a2), mRNA [NM_008577] |
KLA | 1.06 |
1.17 |
1.22 |
1.36 |
1.88 |
2.67 |
2.25 |
| ATP | 1.14 |
1.24 |
1.06 |
1.59 |
3.01 |
3.67 |
3.36 |
| KLA/ATP | 1.33 |
1.32 |
.99 |
1.86 |
2.84 |
5.04 |
6.15 |
|
| Slc6a19 |  |
NM_028878 |
solute carrier family 6 (neurotransmitter transporter), member 19 (Slc6a19), mRNA [NM_028878] |
KLA | 1.22 |
1.21 |
1.43 |
1.38 |
1.20 |
1.18 |
1.42 |
| ATP | 1.04 |
.97 |
.99 |
1.05 |
1.41 |
1.62 |
2.29 |
| KLA/ATP | 1.29 |
1.25 |
1.17 |
1.11 |
1.35 |
3.70 |
7.99 |
|
| Slc7a7 |  |
NM_011405 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 (Slc7a7), mRNA [NM_011405] |
KLA | 2.82 |
2.58 |
3.11 |
3.55 |
3.56 |
3.76 |
2.46 |
| ATP | 1.11 |
.90 |
1.16 |
1.02 |
1.11 |
.77 |
1.38 |
| KLA/ATP | 2.86 |
2.72 |
3.47 |
2.07 |
2.38 |
1.21 |
1.55 |
|
| Slc7a8 |  |
NM_016972 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 (Slc7a8), mRNA [NM_016972] |
KLA | 1.16 |
1.13 |
1.06 |
1.25 |
1.52 |
3.30 |
2.20 |
| ATP | .99 |
.98 |
1.13 |
.83 |
1.01 |
1.55 |
2.41 |
| KLA/ATP | 1.14 |
1.08 |
1.31 |
1.10 |
1.19 |
1.98 |
4.14 |
|
| Slc7a9 |  |
NM_021291 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 (Slc7a9), mRNA [NM_021291] |
KLA | 1.17 |
1.19 |
1.34 |
1.09 |
1.12 |
1.10 |
1.17 |
| ATP | 1.00 |
1.08 |
1.11 |
1.05 |
1.06 |
.98 |
1.21 |
| KLA/ATP | 1.24 |
1.33 |
1.23 |
1.32 |
1.09 |
1.10 |
1.32 |
|
| Slc8a1 |  |
AF004666 |
sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] |
KLA | 1.13 |
1.10 |
1.22 |
1.44 |
1.52 |
1.55 |
1.10 |
| ATP | 1.03 |
1.05 |
1.22 |
1.12 |
.65 |
.49 |
.67 |
| KLA/ATP | 1.04 |
1.21 |
1.30 |
1.44 |
.81 |
.63 |
1.01 |
|
| Slc8a1 | |
AF108396 |
sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] |
KLA | 1.07 |
1.18 |
1.30 |
1.22 |
1.31 |
1.39 |
1.21 |
| ATP | 1.03 |
1.02 |
1.10 |
1.07 |
.88 |
.91 |
1.23 |
| KLA/ATP | 1.15 |
1.17 |
1.14 |
1.22 |
.96 |
1.01 |
1.77 |
|
| Slc8a1 | |
NM_011406 |
solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] |
KLA | 1.12 |
1.16 |
1.22 |
1.25 |
1.35 |
1.33 |
1.11 |
| ATP | 1.03 |
1.04 |
1.07 |
1.10 |
.93 |
.90 |
1.19 |
| KLA/ATP | 1.13 |
1.24 |
1.19 |
1.16 |
.93 |
1.06 |
1.62 |
|
| Slc8a2 |  |
NM_148946 |
solute carrier family 8 (sodium/calcium exchanger), member 2 (Slc8a2), mRNA [NM_148946] |
KLA | 1.14 |
1.11 |
1.17 |
1.21 |
1.17 |
1.21 |
1.09 |
| ATP | .96 |
.87 |
1.22 |
1.12 |
1.15 |
.96 |
1.01 |
| KLA/ATP | 1.16 |
1.15 |
1.30 |
1.23 |
1.22 |
.95 |
1.00 |
|
| Slc8a3 |  |
AK139260 |
7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730083B07 product:solute carrier family 8 (sodium [AK139260] |
KLA | .96 |
1.03 |
1.02 |
.95 |
.99 |
1.03 |
.95 |
| ATP | .95 |
.99 |
.98 |
.94 |
1.02 |
.96 |
1.09 |
| KLA/ATP | 1.02 |
.98 |
1.00 |
.88 |
.91 |
.97 |
1.03 |
|
| Slc8a3 | |
NM_080440 |
solute carrier family 8 (sodium/calcium exchanger), member 3 (Slc8a3), mRNA [NM_080440] |
KLA | 1.01 |
.99 |
.94 |
1.03 |
.98 |
1.02 |
1.03 |
| ATP | .95 |
1.01 |
1.04 |
.92 |
.95 |
1.00 |
1.05 |
| KLA/ATP | .97 |
.99 |
1.06 |
.97 |
.99 |
.95 |
1.06 |
|
| Slc9a3 |  |
AK033564 |
adult male colon cDNA, RIKEN full-length enriched library, clone:9030624O13 product:SODIUM [AK033564] |
KLA | .96 |
.94 |
.91 |
.97 |
.95 |
1.03 |
.99 |
| ATP | 1.06 |
1.02 |
1.01 |
.95 |
.90 |
.95 |
1.08 |
| KLA/ATP | .97 |
.91 |
.93 |
.95 |
1.02 |
1.03 |
1.01 |
|
| Xpnpep2 |  |
NM_133213 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound (Xpnpep2), transcript variant 1, mRNA [NM_133213] |
KLA | .98 |
1.01 |
1.00 |
1.03 |
.99 |
.97 |
.97 |
| ATP | 1.02 |
.94 |
.99 |
1.01 |
1.01 |
.95 |
1.00 |
| KLA/ATP | .93 |
1.05 |
.98 |
.98 |
1.00 |
1.01 |
1.07 |
|
: View data/graphs for replicates
ATP
ATP+KLA